LEIDEN, The Netherlands and SEATTLE, May 3, 2011 - ProFibrix B.V., a leader in the development of innovative products that help stop bleeding (hemostasis) after surgery, today announced the successful closing of a series B follow-on financing. In conjunction with the financing and to support the company's next stage of development towards commercialization, ProFibrix also announced several management and Supervisory Board appointments.

CAMBRIDGE, England, May 3, 2011 - Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved multiple early milestones in its fragment-based drug discovery collaboration with GlaxoSmithKline which commenced in November 2009. Total milestone payments received under the collaboration have now reached GBP5.9 million.

LONDON, May 3, 2011 - MCDC, the data centre division of Matterhorn Capital, formally announces a GBP250 million investment in two landmark data centre sites in South East England. The investment comprises purchase of the sites and construction capital expenditure. Both new data centre sites have full planning consent.

Less Stress and More Fuel Efficient BOULOGNE, France, May 3, 2011 - Heading to awkward built-up areas, congestion on major roads, overconsumption of fuel. ViaMichelin advises motorists to prepare their journeys and check traffic conditions before taking to the wheel.

PEM Now Available as Tool to Help Italian Women in the Fight against Breast Cancer